uz
Feedback
Marrow Notes

Marrow Notes

Kanalga Telegram’da oā€˜tish

Ko'proq ko'rsatish

šŸ“ˆ Telegram kanali Marrow Notes analitikasi

Marrow Notes (@marrow_edition9notes) Ingliz til segmentidagi kanali faol ishtirokchi. Hozirda hamjamiyat 125 166 obunachidan iborat bo'lib, Tibbiyot toifasida 80-o'rinni va Hindiston mintaqasida 1 851-o'rinni egallagan.

šŸ“Š Auditoriya koā€˜rsatkichlari va dinamika

невіГомо sanasidan buyon loyiha tez oā€˜sib, 125 166 obunachiga ega boā€˜ldi.

26 Iyul, 2026 dagi oxirgi ma’lumotlarga koā€˜ra kanal barqaror faollikka ega. Oxirgi 30 kunda obunachilar soni 105 ga, soā€˜nggi 24 soatda esa 0 ga oā€˜zgardi va umumiy qamrov yuqori darajada qolmoqda.

  • Tasdiqlash holati: Tasdiqlanmagan
  • Jalb etish (ER): Auditoriya oā€˜rtacha 23.34% darajada jalb etiladi. Nashrdan keyingi dastlabki 24 soatda kontent odatda umumiy obunachilar sonining N/A% ini tashkil etuvchi reaksiyalarni toā€˜playdi.
  • Post qamrovi: Har bir post oā€˜rtacha 0 marta koā€˜riladi; birinchi sutkada odatda 0 ta koā€˜rish yigā€˜iladi.
  • Reaksiyalar va oā€˜zaro ta’sir: Auditoriya faol: har bir postga oā€˜rtacha 0 ta reaksiya keladi.

šŸ“ Tavsif va kontent siyosati

Kanal uchun tavsif kiritilmagan.

Yuqori yangilanish chastotasi (oxirgi ma’lumot 27 Iyul, 2026 da olingan) sababli kanal doimo dolzarb va katta qamrovli boā€˜lib qoladi. Analitika auditoriya kontent bilan faol hamkorlik qilishini, uni Tibbiyot toifasidagi muhim ta’sir nuqtasiga aylantirishini koā€˜rsatadi.

125 166
Obunachilar
Ma'lumot yo'q24 soatlar
+497 kunlar
+10530 kunlar

Ma'lumot yuklanmoqda...

O'xshash kanallar
Ma'lumot yo'q
Muammo bormi? Iltimos, sahifani yangilang yoki bizning qo'llab-quvvatlash boshqaruvchimizga murojaat qiling>.
Taglar buluti
Ma'lumot yo'q
Muammo bormi? Iltimos, sahifani yangilang yoki bizning qo'llab-quvvatlash boshqaruvchimizga murojaat qiling>.
Kirish va chiqish esdaliklari
---
---
---
---
---
---
Obunachilarni jalb qilish
Iyul '26
Iyul '26
+308
0 kanalda
Iyun '26
+130
0 kanalda
Get PRO
May '26
+308
0 kanalda
Get PRO
Aprel '26
+471
2 kanalda
Get PRO
Mart '26
+411
0 kanalda
Get PRO
Fevral '26
+1 205
0 kanalda
Get PRO
Yanvar '26
+1 453
0 kanalda
Get PRO
Dekabr '25
+1 214
1 kanalda
Get PRO
Noyabr '25
+1 003
0 kanalda
Get PRO
Oktabr '250
0 kanalda
Get PRO
Sentabr '250
0 kanalda
Get PRO
Avgust '250
0 kanalda
Get PRO
Iyul '250
0 kanalda
Get PRO
Iyun '250
0 kanalda
Get PRO
May '250
0 kanalda
Get PRO
Aprel '25
+1
0 kanalda
Get PRO
Mart '25
+1
0 kanalda
Get PRO
Fevral '250
0 kanalda
Get PRO
Yanvar '250
0 kanalda
Get PRO
Dekabr '240
0 kanalda
Get PRO
Noyabr '240
0 kanalda
Get PRO
Oktabr '240
0 kanalda
Get PRO
Sentabr '24
+1 477
0 kanalda
Get PRO
Avgust '24
+1 441
0 kanalda
Get PRO
Iyul '24
+1 735
0 kanalda
Get PRO
Iyun '24
+1 849
0 kanalda
Get PRO
May '24
+3 870
0 kanalda
Get PRO
Aprel '240
0 kanalda
Get PRO
Mart '24
+2 024
0 kanalda
Get PRO
Fevral '24
+1 241
0 kanalda
Get PRO
Yanvar '24
+1 364
0 kanalda
Get PRO
Dekabr '23
+13 105
0 kanalda
Get PRO
Noyabr '230
0 kanalda
Get PRO
Oktabr '230
0 kanalda
Get PRO
Sentabr '230
0 kanalda
Get PRO
Avgust '230
0 kanalda
Get PRO
Iyul '230
0 kanalda
Get PRO
Iyun '230
0 kanalda
Get PRO
May '230
0 kanalda
Get PRO
Aprel '230
0 kanalda
Get PRO
Mart '23
+3 881
0 kanalda
Get PRO
Fevral '230
0 kanalda
Get PRO
Yanvar '230
0 kanalda
Get PRO
Dekabr '22
+1 482
0 kanalda
Get PRO
Noyabr '22
+1 805
0 kanalda
Get PRO
Oktabr '22
+1 736
0 kanalda
Get PRO
Sentabr '22
+3 416
0 kanalda
Get PRO
Avgust '22
+4 091
0 kanalda
Get PRO
Iyul '22
+8 254
0 kanalda
Get PRO
Iyun '22
+8 833
0 kanalda
Get PRO
May '22
+7 177
0 kanalda
Get PRO
Aprel '22
+7 855
0 kanalda
Get PRO
Mart '22
+9 952
0 kanalda
Get PRO
Fevral '22
+6 594
0 kanalda
Get PRO
Yanvar '22
+3 680
0 kanalda
Get PRO
Dekabr '21
+66
0 kanalda
Get PRO
Noyabr '21
+4 539
0 kanalda
Get PRO
Oktabr '21
+5 844
0 kanalda
Get PRO
Sentabr '21
+5 426
0 kanalda
Get PRO
Avgust '21
+5 610
0 kanalda
Get PRO
Iyul '21
+8 481
0 kanalda
Get PRO
Iyun '21
+4 907
0 kanalda
Get PRO
May '21
+5 065
0 kanalda
Get PRO
Aprel '21
+3 697
0 kanalda
Get PRO
Mart '21
+2 630
0 kanalda
Get PRO
Fevral '21
+2 268
0 kanalda
Sana
Obunachilarni jalb qilish
Esdaliklar
Kanallar
27 Iyul+3
26 Iyul+1
25 Iyul+7
24 Iyul+21
23 Iyul+13
22 Iyul+12
21 Iyul+10
20 Iyul+16
19 Iyul+3
18 Iyul+15
17 Iyul+9
16 Iyul+4
15 Iyul+18
14 Iyul+33
13 Iyul+2
12 Iyul+13
11 Iyul+5
10 Iyul+9
09 Iyul+3
08 Iyul+35
07 Iyul+20
06 Iyul+7
05 Iyul0
04 Iyul+18
03 Iyul+12
02 Iyul+1
01 Iyul+18
Kanal postlari
Malignant testicular neoplasms Type Features Germ cell (95%)Seminoma• Retain features of spermatogenesis • β-hCG, AFP usually negative Nonseminoma• ≄1 partially differentiated cells: yolk sac, embryonal carcinoma, teratoma, and/or choriocarcinoma • β-hCG, AFP usually positive Stromal (5%)Leydig• Often produces excessive estrogen (gynecomastia) or testosterone (acne) • Can cause precocious puberty Sertoli• Rare • Occasionally associated with excessive estrogen secretion (eg, gynecomastia) AFP = alpha-fetoprotein. This patient with a testicular mass, gynecomastia, and elevated estrogen levels likely has a Leydig cell tumor, the most common type of testicular sex cord stromal tumor. These tumors arise from supporting cells of the testis such as Leydig, Sertoli, and granulosa cells; they account for approximately 5% of testicular tumors (germ cell tumors account for ~95%), arise in a wide range of ages, and have no clearly defined risk factors. Leydig cells are the primary source of testicular testosterone but are also capable of generating estrogen. Therefore, Leydig cell tumors often present with endocrine manifestations due to excessive estrogen (eg, gynecomastia, loss of libido, erectile dysfunction) or testosterone (eg, acne, hirsutism). Examination frequently reveals a testicular mass, which is typically confirmed by bilateral scrotal ultrasound. In contrast to many germ cell tumors, Leydig cells do not generally produce serum tumor markers such as β-hCG or alpha-fetoprotein (AFP). However, the generation of estrogen or testosterone often leads to FSH and LH suppression. (Choices A, D, and E) Choriocarcinoma, teratoma, and yolk sac tumors are nonseminomatous germ cell tumors. They typically present with a painless, firm testicular mass. However, they often produce β-hCG (particularly choriocarcinoma) or AFP (particularly yolk sac tumors) in addition; estrogen production is rare, so feminization is uncommon. (Choice C) Seminoma is a germ cell tumor that does not usually produce β-hCG, AFP, or estrogen. Therefore, feminization would be atypical. Most seminomas present with a painless, unilateral testicular mass or swelling. TAKE HOME MESSAGE Leydig cell testicular tumors often cause feminization (eg, gynecomastia) due to the production of estrogen by tumor cells. This frequently causes secondary inhibition of FSH and LH. Serum tumor markers (eg, β-hCG, AFP) are not usually elevated.

2
Which of the following is the most likely diagnosis in this patient? #NEETPG #INICET
30 001
3
A 35-year-old man comes to the office due to a progressive increase in breast size over the past 6 months. He is sexually active, has no chronic medical conditions, and takes no medications. The patient does not use tobacco, alcohol, or illicit drugs. Vital signs are normal. BMI is 28 kg/m². Gynecomastia with mild bilateral breast tenderness is present. Genitourinary examination reveals a 1-cm nodule in the right testis. The examination is otherwise normal. Laboratory results are as follows: LH: 3 U/L (normal: 6–23 U/L) FSH: 2 U/L (normal: 4–25 U/L) Testosterone: 270 ng/dL (normal: 300–1,000 ng/dL) Estradiol: 115 pg/mL (normal: 20–60 pg/mL) β-hCG: undetectable Alpha-fetoprotein: undetectable
28 384
4
Join PROFWISE MBBS Groups! 1. 1st PROF MBBS: https://t.me/+rMA2Sew_gp41MDk1 2. 2nd PROF MBBS: https://t.me/+SD0oh2UMHAFmNjM1 3. 3rd PROF MBBS: https://t.me/+yxj_Ruzm37o0MDY1 4. FINAL PROF MBBS: https://t.me/+WQnwlzhiBU1hMTc1 5. FMGE (Abroad MBBS): https://t.me/FMGEgroupstudents 6. NEET PG/INICET (Interns/Post-interns): https://t.me/+TfvNbL3UWlw1NWI1 7. NEET SS/INI SS (Residents): https://t.me/Neet_SS Join respective group only! āš ļø Queries: https://t.me/murtazakuchay (@murtazakuchay) šŸ’¬
1